Search results
Study: For treating retinopathy of prematurity, UB-led research proves that ranibizumab is safe
UB Reporter· 2 days agoROP occurs in low birthweight premature babies; if not treated, it can lead to blindness. The study, published in eClinicalMedicine online before print on April 11, answers a longstanding concern ...
A Dietician Explains the Difference Between Chlorella and Spirulina—Do You Know Which Is Healthier?
Health.com· 6 days agoSpirulina and chlorella are types of microalgae commonly taken in supplement form. They share some...
Apellis' (APLS) Q1 Earnings Match Estimates, Revenues Beat
Zacks· 6 days agoFree Report) incurred a first-quarter 2024 loss of 54 cents per share, which matched the Zacks Consensus Estimate. Total revenues amounted to $172.3 million in the reported quarter, beating ...
Lineage Cell Therapeutics Q1 2024 Earnings: Aligns with EPS Proj
Guru Focus· 2 days agoOn May 9, 2024, Lineage Cell Therapeutics Inc (LCTX, Financial) disclosed its financial results for the first quarter of 2024 through an 8-K filing. The clinical-stage biotechnology company, ...
Outlook Therapeutics, Inc. (NASDAQ:OTLK) Receives $46.43 Average Target Price from Analysts
ETF DAILY NEWS· 2 days agoShares of Outlook Therapeutics, Inc. (NASDAQ:OTLK – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the eight research firms that are covering the firm, Marketbeat ...
Skye Bioscience (NASDAQ:SKYE) Shares Down 1.8%
ETF DAILY NEWS· 4 days agoSkye Bioscience, Inc. (NASDAQ:SKYE – Get Free Report)’s stock price was down 1.8% during trading on Wednesday . The company traded as low as $12.32 and last traded at $12.50. Approximately 29,170 ...
Nanoscope Therapeutics Announces Presentations in Upcoming ASGCT Annual Meeting and Retina World...
FOX 5 San Diego· 5 days agoDALLAS, May 7, 2024 /PRNewswire/ -- Nanoscope Therapeutics Inc., a late-stage clinical biotechnology company developing gene therapies for retinal degenerative diseases, today announced that ...
HC Wainwright Reaffirms “Buy” Rating for Lineage Cell Therapeutics (NYSEAMERICAN:LCTX)
ETF DAILY NEWS· 4 days agoHC Wainwright reissued their buy rating on shares of Lineage Cell Therapeutics (NYSEAMERICAN:LCTX – Free Report) in a research report report published on Monday, Benzinga reports. The firm currently ...
Adverum Biotechnologies Reports Q1 2024 Results: A Detailed Look
Guru Focus· 2 days agoOn May 9, 2024, Adverum Biotechnologies Inc (ADVM, Financial), a trailblazer in gene therapy for ocular diseases, disclosed its financial outcomes for the first quarter of 2024 through its 8 ...
Santa J. Ono, University of Michigan President, Joins USJF Board
Quad-City Times· 5 days agoSanta J. Ono, president of the University of Michigan, has joined the United States-Japan Foundation Board of Trustees. Ono, an accomplished medical researcher and leader in higher education ...